Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1997-11-24
|
pubmed:abstractText |
Retinoids have been shown to modulate cell growth and differentiation in a variety of human tumor cell types, but their effects on B-cell non-Hodgkin's lymphomas (NHL-B) have not been explored. In this study, all-trans retinoic acid (ATRA) in the free form and liposome-encapsulated form (L-ATRA) were used to determine effects on fresh NHL-B patient cells as well as cell lines recently established from both HIV-negative and -positive NHL-B patient biopsies. Both ATRA and L-ATRA were found to inhibit cell proliferation in NHL-B cells. However, L-ATRA was found to be superior to free ATRA in inhibiting cell proliferation of NHL-B cells and resulted in greater than 90% cell growth inhibition in a dose-dependent manner. In addition, L-ATRA also induced high levels of apoptosis in NHL-B cells in vitro. To delineate the apoptotic pathways involved, the expression of the apoptosis suppressor oncogene bcl-2 was evaluated in different NHL-B cells with and without the t(14;18) chromosomal translocation. After L-ATRA exposure, more than a 50% reduction in the expression of bcl-2 protein was observed. bcl-2 message levels were also down-regulated in the L-ATRA-sensitive NHL-B cells. Bax protein levels were analyzed and found to be up-regulated in L-ATRA-sensitive NHL-B cells. Similar results were observed in sensitive AIDS/lymphoma cell lines. Experiments using an RAR-alpha antagonist (RO 41-5253) showed that both the proliferation inhibition and apoptosis induced by L-ATRA could be blocked in NHL-B cells. The findings of the present study indicate that L-ATRA may possess therapeutic potential in blocking cell proliferation, inducing apoptosis, and
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/BAX protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoates,
http://linkedlifedata.com/resource/pubmed/chemical/Chromans,
http://linkedlifedata.com/resource/pubmed/chemical/Dosage Forms,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Retinoic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Ro 41-5253,
http://linkedlifedata.com/resource/pubmed/chemical/Tretinoin,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein,
http://linkedlifedata.com/resource/pubmed/chemical/retinoic acid receptor alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1044-9523
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1071-82
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9342185-Apoptosis,
pubmed-meshheading:9342185-Benzoates,
pubmed-meshheading:9342185-Blotting, Western,
pubmed-meshheading:9342185-Cell Division,
pubmed-meshheading:9342185-Chromans,
pubmed-meshheading:9342185-Dosage Forms,
pubmed-meshheading:9342185-Down-Regulation,
pubmed-meshheading:9342185-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:9342185-Humans,
pubmed-meshheading:9342185-Liposomes,
pubmed-meshheading:9342185-Lymphoma, AIDS-Related,
pubmed-meshheading:9342185-Lymphoma, B-Cell,
pubmed-meshheading:9342185-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:9342185-Microscopy, Electron,
pubmed-meshheading:9342185-Proto-Oncogene Proteins,
pubmed-meshheading:9342185-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:9342185-Receptors, Retinoic Acid,
pubmed-meshheading:9342185-Tretinoin,
pubmed-meshheading:9342185-Tumor Cells, Cultured,
pubmed-meshheading:9342185-bcl-2-Associated X Protein
|
pubmed:year |
1997
|
pubmed:articleTitle |
Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
|
pubmed:affiliation |
Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|